New Zealand markets closed

Autolus Therapeutics plc (AUTL)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
4.0200+0.1000 (+2.55%)
At close: 04:00PM EDT
4.0200 0.00 (0.00%)
After hours: 04:00PM EDT
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Total revenue
10,497
1,698
6,194
1,507
242
Operating expenses
Research development
133,764
130,481
117,354
110,839
134,888
Selling general and administrative
55,638
46,745
31,899
31,865
34,972
Total operating expenses
189,402
177,226
149,087
141,881
168,387
Operating income or loss
-178,905
-175,528
-142,893
-140,374
-168,145
Interest expense
59,431
45,067
8,905
1,105
0
Total other income/expenses net
69
-1,312
1,523
-821
1,352
Income before tax
-221,275
-208,402
-148,567
-142,038
-166,257
Income tax expense
-13
-19
272
58
-24,163
Income from continuing operations
-221,262
-208,383
-148,839
-142,096
-142,094
Net income
-221,262
-208,383
-148,839
-142,096
-142,094
Net income available to common shareholders
-221,262
-208,383
-148,839
-142,096
-142,094
Basic EPS
-0.98
-1.20
-1.57
-1.97
-2.76
Diluted EPS
-0.98
-1.20
-1.57
-1.97
-2.76
Basic average shares
157,140
173,942
94,993
72,084
51,558
Diluted average shares
157,140
173,942
94,993
72,084
51,558